

[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - Market Wire
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - Market Wire
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
[ Fri, Aug 24th 2012
] - WOPRAI
Gena Wang Initiated (BMRN) at Buy and Held Target at $46 on, Aug 24th, 2012
Gena Wang of Barclays, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Buy and Held Target at $46 on, Aug 24th, 2012.
Gena has made no other calls on BMRN in the last 4 months.
There is 1 other peer that has a rating on BMRN. Out of the 1 peers that are also analyzing BMRN, 0 agree with Gena's Rating of Hold.
This is the rating of the analyst that currently disagrees with Gena
- Matthew Harrison of "Morgan Stanley" Maintained at Strong Buy with Increased Target to $52 on, Monday, July 23rd, 2012
Contributing Sources
Similar Stocks and Investing Articles
[ Thu, Aug 23rd 2012
] - WOPRAI
[ Mon, Jul 23rd 2012
] - WOPRAI
[ Fri, Jul 06th 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Tue, May 01st 2012
] - WOPRAI
[ Wed, Apr 25th 2012
] - WOPRAI
[ Thu, Apr 19th 2012
] - WOPRAI
[ Tue, Mar 27th 2012
] - WOPRAI
[ Mon, Mar 19th 2012
] - WOPRAI
[ Tue, Mar 06th 2012
] - WOPRAI